658 related articles for article (PubMed ID: 26414932)
21. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
[TBL] [Abstract][Full Text] [Related]
22. Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.
Yang Y; Zhang X; Yi L; Hou Z; Chen J; Kou X; Zhao Y; Wang H; Sun XF; Jiang C; Wang Y; Gao S
Stem Cells Transl Med; 2016 Jan; 5(1):8-19. PubMed ID: 26676643
[TBL] [Abstract][Full Text] [Related]
23. Enhanced CRISPR/Cas9-mediated biallelic genome targeting with dual surrogate reporter-integrated donors.
Wu Y; Xu K; Ren C; Li X; Lv H; Han F; Wei Z; Wang X; Zhang Z
FEBS Lett; 2017 Mar; 591(6):903-913. PubMed ID: 28214366
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9-based photoactivatable transcription system.
Nihongaki Y; Yamamoto S; Kawano F; Suzuki H; Sato M
Chem Biol; 2015 Feb; 22(2):169-74. PubMed ID: 25619936
[TBL] [Abstract][Full Text] [Related]
25. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
26. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
Dettmer R; Naujok O
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
[TBL] [Abstract][Full Text] [Related]
27. TALEN/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm.
Krentz NA; Nian C; Lynn FC
PLoS One; 2014; 9(12):e114275. PubMed ID: 25474420
[TBL] [Abstract][Full Text] [Related]
28. Generation of two ISL1-tdTomato reporter human induced pluripotent stem cell lines using CRISPR-Cas9 genome editing.
Tsukamoto S; Nakade K; Wakabayashi T; Nakashima K; Takami M; Hemmi Y; Kuramochi Y; Shimizu T; Arai Y; Matsuo-Takasaki M; Noguchi M; Nakamura Y; Miwa Y; Hayashi Y
Stem Cell Res; 2021 May; 53():102363. PubMed ID: 34087992
[TBL] [Abstract][Full Text] [Related]
29. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
[TBL] [Abstract][Full Text] [Related]
30. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9.
Nakade S; Tsubota T; Sakane Y; Kume S; Sakamoto N; Obara M; Daimon T; Sezutsu H; Yamamoto T; Sakuma T; Suzuki KT
Nat Commun; 2014 Nov; 5():5560. PubMed ID: 25410609
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
Auer TO; Del Bene F
Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9-Mediated Targeted Knockin of Exogenous Reporter Genes in Zebrafish.
Kawahara A
Methods Mol Biol; 2017; 1630():165-173. PubMed ID: 28643258
[TBL] [Abstract][Full Text] [Related]
33. A Guide to Computational Tools and Design Strategies for Genome Editing Experiments in Zebrafish Using CRISPR/Cas9.
Prykhozhij SV; Rajan V; Berman JN
Zebrafish; 2016 Feb; 13(1):70-3. PubMed ID: 26683213
[TBL] [Abstract][Full Text] [Related]
34. Generation of a
Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
[TBL] [Abstract][Full Text] [Related]
35. Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.
Takayama K; Igai K; Hagihara Y; Hashimoto R; Hanawa M; Sakuma T; Tachibana M; Sakurai F; Yamamoto T; Mizuguchi H
Nucleic Acids Res; 2017 May; 45(9):5198-5207. PubMed ID: 28334759
[TBL] [Abstract][Full Text] [Related]
36. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish.
Hisano Y; Sakuma T; Nakade S; Ohga R; Ota S; Okamoto H; Yamamoto T; Kawahara A
Sci Rep; 2015 Mar; 5():8841. PubMed ID: 25740433
[TBL] [Abstract][Full Text] [Related]
37. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C
F1000Res; 2019; 8():1911. PubMed ID: 32789000
[No Abstract] [Full Text] [Related]
38. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
Li Y; Li S; Li Y; Xia H; Mao Q
Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
[TBL] [Abstract][Full Text] [Related]
40. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
